Inovio Pharmaceuticals, Inc. (INO) was a big mover last session, as its shares rose nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the trend for the healthcare company, as the stock is now up over 46% in the past one-month timeframe.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Inovio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Cambrex Corporation. (CBM), Emergent BioSolutions, Inc. (EBS) and Biogen Idec Inc. (BIIB). While Emergent BioSolutions and Biogen sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Be the first to comment